Open Heart

MAY 9, 2022

Objective To identify the most common transthoracic echocardiogram (TTE) parameters in patients hospitalised with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2/COVID-19) and their association with myocardial injury and outcomes. Moreover, COVID-19-induced myocarditis remains extremely rare.

COVID-19 52

COVID-19 Inpatient Risk Factors Echocardiogram 52

Dr. Anish Koka

FEBRUARY 6, 2023

I’m a cardiologist, and the first disconnect that became glaringly obvious very quickly was the impact COVID was having on the heart. As I walked through COVID rooms in the Spring of 2020 trying to hold my breath, I waited for a COVID cardiac tsunami. There never was a cardiac tsunami from COVID.

COVID-19 52

COVID-19 Chest Pain Academic Hospital 52

Journal of the American Heart Association

JANUARY 31, 2024

BackgroundPatients with ischemic stroke and concomitant COVID‐19 infection have worse outcomes than those without this infection, but the impact of COVID‐19 on hemorrhagic stroke remains unclear. We aimed to assess if COVID‐19 worsens outcomes in intracerebral hemorrhage (ICH).Methods

COVID-19 40

COVID-19 Hemorrhage Outcomes Nursing 40

Stroke Journal

JANUARY 30, 2025

Background:COVID-19, primarily a respiratory illness caused by SARS-CoV-2, is associated with vascular complications like ischemia due to endothelial injury, hypercoagulability, and inflammation. Results:Out of 1,171 patients, those who tested positive for COVID-19 had significantly worse outcomes.

COVID-19 40

COVID-19 Stroke Strokes Outcomes 40

Open Heart

AUGUST 30, 2024

Background The COVID-19 pandemic disrupted cardiovascular disease management in primary care in England. OpenSAFELY can be used to continuously monitor changes in national quality-of-care schemes to identify changes in key clinical subgroups early and support prioritisation of recovery from care disrupted by COVID-19.

COVID-19 52

COVID-19 Blood Pressure Hypertension Outcomes 52

Stroke Journal

FEBRUARY 1, 2024

Background:Hemorrhagic cerebrovascular manifestations are known to be associated with COVID-19. Comparative outcome analyses between pre-COVID (2016-2019) and COVID year (2020) were performed. Comparative outcome analyses between pre-COVID (2016-2019) and COVID year (2020) were performed.

COVID-19 40

COVID-19 Hemorrhage Outcomes Inpatient 40

Open Heart

JULY 17, 2023

This study aimed to identify predictors of worse clinical outcome after deferral of non-emergency cardiovascular interventions. Methods This observational case-control study included consecutive patients whose non-emergency cardiac intervention has been postponed during COVID-19-related lockdown between 19 March and 30 April 2020 (n=193).

COVID-19 52

COVID-19 Outcomes Cardiovascular Interventions Risk Factors 52

Circulation

NOVEMBER 11, 2024

Background:Different from the negative impact of COVID-19 pandemic on outcomes after out-of-hospital cardiac arrest (OHCA) collapsed before emergency medical service (EMS) arrival, there was a report suggested that COVID-19 pandemic did not affect outcomes after OHCA witnessed by EMS personnel.

COVID-19 40

COVID-19 Cardiac Arrest Outcomes Hospital 40

Stroke Journal

DECEMBER 21, 2023

BACKGROUND:The association of COVID-19 with higher bleeding risk and worse outcomes in acute ischemic stroke (AIS) undergoing revascularization may be related to the presence of infection symptoms. We compared COVID-negative controls, AS-COVID, and S-COVID using multivariable regression. versus 85.6%;P<0.001),

COVID-19 40

COVID-19 Outcomes Stroke Strokes 40

Stroke Journal

JANUARY 30, 2025

Whether the COVID-19 pandemic impacted stroke etiology is still being investigated, but most studies have been performed outside the United States. Adults (18) with AIS were compared based on admission date: Pre-COVID period (1/1/2019 12/31/2019) vs. COVID period (3/1/2020 3/1/2021).

COVID-19 40

COVID-19 Stroke Strokes Outcomes 40

Stroke Journal

FEBRUARY 1, 2024

Background:Coronavirus disease 2019 (COVID-19) increases the risk of cerebral venous sinus thrombosis (CVST), and previous reports derived from small case series reported a high mortality in these patients, up to 40%. but there were fewer women in the COVID-CVST group (50% vs 68%,P<0.01).

COVID-19 40

COVID-19 Thrombosis Outcomes Hospital 40

Open Heart

JULY 17, 2023

Background COVID-19 has caused significant worldwide morbidity and mortality. Congenital heart disease (CHD) is likely to increase vulnerability and understanding the predictors of adverse outcomes is key to optimising care. Methods Multicentre UK study undertaken 1 March 2020–30 June 2021 during the COVID-19 pandemic.

COVID-19 40

COVID-19 Congenital Heart Disease Congenital Heart Disease 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

IntroductionThe coronavirus disease 2019 (COVID‐19) pandemic has had a global impact on healthcare systems. There is limited data on the influence of COVID‐19 on treatment and outcomes in patients with intracranial aneurysms. Of these, 45,979 occurred pre‐COVID and 11,736 during the COVID pandemic period.

COVID-19 40

COVID-19 Aneurysm Outcomes Inpatient 40

Society of Thoracic Surgeons - Research

APRIL 12, 2021

The onset of the pandemic and the related public health emergency in early 2020 presented an opportunity for the Network to expand its focus beyond cardiac surgery and help design and execute COVID-19 studies. The performance of the Network has been spectacular,” said Peter K.

COVID-19 40

COVID-19 Research Cardiothoracic Public Health 40

Circulation

NOVEMBER 11, 2024

Background:Severe COVID-19 infection has been associated with acute respiratory distress syndrome (ARDS) and right ventricular (RV) dysfunction. A retrospective chart review was performed on 41 patients with COVID-19 on ECMO between March and October 2020.

COVID-19 40

COVID-19 Laboratory Biomarkers Echocardiogram 40

Stroke Journal

FEBRUARY 1, 2024

Background:Nationwide data demonstrating the impact of the COVID-19 pandemic on hemorrhagic stroke outcomes are lacking.Methods:We used the National Inpatient Sample (2016-2020) to identify adults (>=18 years) with primary intracerebral hemorrhage (ICH) or subarachnoid hemorrhage (SAH). 2.51; SAH: 2.76, 1.68-4.54),

COVID-19 40

COVID-19 Hemorrhage Public Health Inpatient 40

Journal of the American Heart Association

MARCH 21, 2025

However, the association of socioeconomic vulnerability and outcomes after hospitalization is uncertain.Methods and ResultsAmerican Heart Association COVID19 Cardiovascular Disease Registry hospitalizations between March 1, 2020, and June 30, 2022, linked with Medicare feeforservice claims, were analyzed.

COVID-19 40

COVID-19 Medicare Cardiogenic Shock Hospital 40

Stroke Journal

FEBRUARY 1, 2024

However, limited information exists on how demographic and clinical factors are associated with social inequities among older patients hospitalized with acute ischemic stroke (AIS) during COVID-19.Methods:We NIHSS ≥20 vs 8.4%), more history of COVID-19 (7.7% All patients were followed until March 31, 2023.

Medicare 40

Medicare COVID-19 Hospital Stroke 40

American College of Cardiology

FEBRUARY 1, 2025

These findings, exacerbated by the COVID-19 pandemic, point to an uneven playing field where communities burdened by poverty, segregation and limited health care access face markedly shorter lifespans. COVID-19 set them even further behind the other Americas, with a 6.6-year years in 2020. years in 2020.

COVID-19 40

COVID-19 Education Health Disparities Certification 40

Coronary Artery Disease Journal

MAY 26, 2024

Background Patients with cardiovascular disease (CVD) and risk factors have increased rates of adverse events and mortality after hospitalization for coronavirus disease 2019 (COVID-19). In this study, we attempted to identify and assess the effects of CVD on COVID-19 hospitalizations in the USA using a large national database.

COVID-19 40

COVID-19 Cardiovascular Disease Hospital Coronary Artery Disease 40

Dr. Smith's ECG Blog

NOVEMBER 12, 2020

This is a 30-something healthy patient presented with COVID pneumonia who presented to the ED. An elevated troponin in a COVID patient confers about 4x the risk of mortality than a normal one. Beware elevated troponins in COVID patients. He was moderately hypoxic. There is minimal, probably normal STE in V2-V6. 3–8 Shi et al.

Cardiac Arrest 52

Cardiac Arrest COVID-19 Myocardial Infarction Cardiogenic Shock 52

The British Journal of Cardiology

APRIL 16, 2024

We evaluated a novel rapid-access general cardiology clinic to achieve this, implemented during the COVID-19 pandemic. There were 216 ED referrals made between 1 June and 30 October 2020. The median time to review was two days (interquartile range 1–5).

COVID-19 40

COVID-19 Outpatient General Cardiology Outcomes 40

Dr. Anish Koka

FEBRUARY 13, 2023

Arthur Reingold, an epidemiology professor at UC-Berkeley, notes that UC also requires immunizations for measles and chickenpox, and people still are dying from COVID at rates that exceed those for influenza. 1, there were more than 400 COVID deaths a day across the U.S. And yet, there is no uptick in myocarditis cases in 2020.

COVID-19 52

COVID-19 Public Health Pediatrics Chest Pain 52

Ken Grauer, MD

FEBRUARY 28, 2023

The ECG and long lead II rhythm strip in Figure-1 — was obtained from a COVID positive patient with persistent tachycardia not responding to Diltiazem. Applying the Above to Today's Case: In addition to being Covid-positive — the patient in today's case had longstanding COPD. How would YOU interpret this tracing?

Blog 78

Blog COVID-19 AFIB Pulmonary 78

Society of Thoracic Surgeons - Critical Care

MARCH 2, 2022

Our work suggests that with appropriately selected patients and aggressive management strategies, the use of ECMO support for severe COVID-19 can result in exceptional early survival, and these patients who leave the hospital without the need for oxygen therapy are very likely to remain alive and well 1 year later,” said Deane E.

COVID-19 40

COVID-19 Cardiothoracic ICU Allied Health 40

Dr. Malcolm Kendrick

JANUARY 30, 2023

31st January 2023 With the resignation of Jacinda Ardern, my thoughts were dragged back to Covid once more. But it got me thinking about lockdowns again and the whole worldwide madness of Covid. During the Covid pandemic I travelled far past angry, to reach a point of utter weariness. The only outcome that really matters.

COVID-19 52

COVID-19 Article Nursing Cancer 52

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

Countries in the region of interest were categorized into three groups based on stroke and COVID‐19 data. Interns also developed interventions to address key barriers identified during the research.ResultsThe first cohort (2020) comprised 8 interns who investigated barriers to stroke treatment across different regions.

Research 40

Research COVID-19 Public Health Stroke 40

Open Heart

FEBRUARY 4, 2025

Background Studies have shown an increased risk of cardiac disease following COVID-19, but how it compares to pneumonia of other etiologies is unclear. Aims To determine the incidence and HRs of cardiac disease in patients hospitalised with COVID-19 compared with other viral or bacterial pneumonias.

COVID-19 52

COVID-19 Myocardial Infarction Atrial Fibrillation Heart Failure 52

Physiologically Speaking

APRIL 26, 2024

At baseline, 3 months, and 6 months, the participants physical activity was measured over a period of 7 days to calculate time spent sitting (the primary study outcome). Rather, they received 10 health coaching sessions about various topics like healthy eating and sleep.

Blood Pressure 52

Blood Pressure Physiology Exercise Diet 52

DAIC

JANUARY 25, 2024

Getty Images milla1cf Thu, 01/25/2024 - 20:47 January 25, 2024 — New research confirms what public health leaders have been fearing: the significant uptick in the cardiovascular disease ( CVD ) death rate that began in 2020 has continued. from 2020 through 2022, in contrast to a decline of 8.9% from 2010 to 2019.

COVID-19 117

COVID-19 Public Health Heart Disease Chronic Disease 117

Stroke Journal

JANUARY 30, 2025

Introduction:In patients with severe COVID-19 infection there is an increased risk of cerebrovascular events, including acute ischemic stroke (AIS). In patients who present with COVID-19 infection and AIS, certain stroke subtypes have been reported with greater frequency. Most patients (94%) had PCR testing.

COVID-19 40

COVID-19 Stroke Strokes Outcomes 40

Stroke Journal

FEBRUARY 1, 2024

Introduction:COVID-19 infection has thus emerged to be a new risk factor for Cerebral Venous Thrombosis (CVT). Our study aimed to compare outcomes of patients diagnosed with CVT within 2 weeks of COVID infection compared to those without COVID-19.Methods:Adult All-cause mortality was the primary outcome.

COVID-19 40

COVID-19 Outcomes Thrombosis Embolism 40

Stroke Journal

JANUARY 30, 2025

Importance:The COVID-19 pandemic significantly disrupted healthcare systems worldwide, impacting the management of acute ischemic stroke (AIS). pre-COVID to 5.5% peri-COVID (p < 0.0001). Men accounted for 50.5% of the cohort. Reperfusion therapy usage increased, with mechanical thrombectomy (MT) rising from 2.2%

COVID-19 40

COVID-19 Inpatient Hospital Outcomes 40

Stroke Journal

JANUARY 30, 2025

Background:The COVID-19 pandemic disrupted healthcare systems and altered patient behaviors, potentially affecting stroke prevalence and outcomes. This study examines trends in stroke-related hospitalizations by age and sex in California from 2016 to 2022, focusing on the pandemic years (2020-2022).Methods:A

COVID-19 40

COVID-19 Hospital Stroke Strokes 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

1–3 Previous work has suggested decreased overall stroke hospitalization volumes, but preserved CVT hospitalization volumes and increased CVT mortality during the COVID‐19 pandemic.4,5 The first wave of the COVID‐19 pandemic was defined as January‐May 2020. in patients with both CVT and COVID (vs.

Thrombosis 40

Thrombosis Inpatient COVID-19 Atrial Fibrillation 40

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52